🔎 Trials Near Me

Hjem › Crohns sykdom › Florida › Tampa

Kliniske studier for Crohns sykdom i Tampa, FL

10 studier for Crohns sykdom søker deltakere på steder i og rundt Tampa (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • USF Health Carol and Frank Morsani Center for Advanced Healthcare ( Site 5039), Tampa
Alder 16 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekruttererFase 2
  • Gcp Clinical Research /ID# 278126, Tampa
  • AdventHealth Medical Group - Tampa - Bruce B Downs Boulevard /ID# 265538, Tampa
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • USF Health Morsani Center for Advanced Healthcare, Tampa
Alder 18 til 75 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • GCP Clinical Research, Tampa
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2/3
  • GCP Clinical Research, Tampa
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • NMC Research LLC-Site Number: 8400033, Tampa
Alder 16 til 80 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • NMC Research LLC-Site Number: 8400033, Tampa
Alder 16 til 80 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekruttererFase 4
  • Alliance Clinical Research of Tampa, LLC, Tampa
Alder 18 til 70 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • GCP Clinical Research, Tampa
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07577843

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • GCP Clinical Research, LLC, Tampa
  • Theia Clinical Research Centers, LLC, Temple Terrace · 7 mi unna
Alder 18 til 75 · Alle kjønn · Oppdatert 27. apr. 2026 · NCT06456593

Crohns sykdom-studier i andre byer

Andre studier i Tampa

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.